See our research disclaimer
On average, patients using Mounjaro lose about 25% of their weight after one year, while those on Wegovy lose around 16%
Descargo de responsabilidad Toda la informacin publicada en el sitio web de OncoHep es solo para fines informativos
Reported benefits (per available research): FDA-approved, clinical-trial-supported reduction of excess visceral abdominal fat in HIV-associated lipodystrophy, the only indication with robust human RCT evidence behind it Studied in a randomized, placebo-controlled trial for possible support of executive function and cognitive performance in healthy older adults and adults with mild cognitive impairment (Baker et al., 2012) Proposed, but far less rigorously studied in healthy or bodybuilding populations, to support lean body mass and body composition changes through GH/IGF-1 axis stimulation
however, it is less efficacious than LRYGB
Listen to Your Body: Fatigue or dizziness may indicate a need to adjust your routine or caloric intake